Vaccine development has moved from an empirical origin to the use of antigenic characterization, structural biology, immune function definition, protein synthesis, and precise definition of immune correlates of protection in order to deal with more difficult biology of current targets.
No takes yet. Share an insight, caveat, or question.
Stanley A. Plotkin (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: